potassium channel blockers (Merck & Co)

N/A

Report date: 2025/02/05 13:46:29
NME

Base Information

Drug Namepotassium channel blockers (Merck & Co)
Drug Alias NamePAC
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockers
TargetsPotassium channelVoltage-gated potassium channel subunit Kv1.3
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A